
At noon today, the hall at the Macedonian Academy of Sciences and Arts (MANU) was too small to accommodate all the guests—academicians, doctors, chemists, and students—who wished to attend the lecture by the world-renowned scientist Svetlana Mojsov. A chemist born in Skopje, as daughter of Yugoslav era diplomat Lazar Mojsov, she conducted research on the GLP-1 hormone that paved the way for revolutionary therapies for diabetes and obesity, including the development of the drug Ozempic.
The entire hall rose to applaud Mojsov when she concluded her lecture, and a long line formed of people wishing to greet her personally and congratulate her on her success. Addressing the packed hall, Mojsov expressed her gratitude for the opportunity to lecture at MANU, adding that she considered it a tremendous honor. Mojsov, who has been working in the USA for 50 years, delivered her remarks in English.
The lecture was titled “GLP-1: Chemistry is Essential—From Potential Peptide to Effective Drugs for Diabetes and Obesity.” The lecture marked her induction as an external member of MANU; she had been elected during the Academy’s Electoral Assembly on November 7, 2025. The award certificate was presented today by the President of MANU, Academician Zhivko Popov, who welcomed her into the ranks of the country’s highest scientific institution.
“I hope it will not be long before you visit Macedonia again,” said Academician Popov.
In his remarks, Academician Dimitar Efremov stated that this award serves as further recognition of her life and professional journey, as well as the scientific achievements through which she has left a profound and lasting mark on contemporary biomedical science.

English